Thromboelastometric evaluation of coagulation profiles of cold-stored autologous whole blood: A prospective observational study

Medicine (United States)

Volumn 98, Issue 39, 2019, Pages

  Iwata, Shihoko ^a   Hirasaki, Yuji ^b   Nomura, Minoru ^a   Ozaki, Makoto ^a  

^a TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^b IMS group IMS Rehabilitation Center   (Japan)

Author keywords

autologous; blood transfusion; fibrinogen; thromboelastometry

Indexed keywords

ANTIVITAMIN K; FIBRINOGEN; HEMOGLOBIN; FIBRIN;

ADULT; ARTICLE; AUTOLOGOUS WHOLE BLOOD; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CRYOPRESERVATION; ELECTIVE SURGERY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PLATELET COUNT; POLYMERIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX SURGERY; THROMBOELASTOGRAPHY; AGED; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CHEMISTRY; COLD; PROCEDURES;

AGED; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; COLD TEMPERATURE; FEMALE; FIBRIN; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; POLYMERIZATION; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; WHOLE BLOOD COAGULATION TIME;

EID: 85072848126     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000017357     Document Type: Article

References (30)

1. Blaudszun G, Butchart A, Klein AA. Blood conservation in cardiac surgery. Transfus Med 2018;28:168-80.
2. Davies L, Brown T, Haynes S, et al. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: A systematic review and economic model. Health Technol Assess 2006;10:44.
3. Dietrich W, Thuermel K, Heyde S, et al. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and costeffectiveness. J Cardiothorac Vasc Anesth 2005;19:589-96.
4. Tsuno NH, Nagura Y, Kawabata M, et al. The current status of autologous blood transfusion in Japan-The importance of pre-deposit autologous blood donation program and the needs to achieve patient blood management. Transfus Apher Sci 2013;49:673-80.
5. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
6. Bolton-Maggs PH, Cohen H. Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013;163:303-14.
7. Pidcoke HF, McFaul SJ, Ramasubramanian AK, et al. Primary hemostatic capacity of whole blood: A comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion 2013;53:137S-49S.
8. Strandenes G, Austlid I, Apelseth TO, et al. Coagulation function of stored whole blood is preserved for 14 days in austere conditions: A ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. J Trauma Acute Care Surg 2015;78:S31-8.
9. Jobes D, Wolfe Y, ONeill D, et al. Toward a definition of "fresh" whole blood: An in vitro characterization of coagulation properties in refrigerated whole blood for transfusion. Transfusion 2011;51:43-51.
10. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012;26:1-3.
11. Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study. Anesthesiology 2011;115:1179-91.
12. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010;113:1205-19.
13. Tanaka KA, Bader SO, Sturgil EL. diagnosis of perioperative coagulopathy-plasma versus whole blood testing. J Cardiothorac Vasc Anesth 2013;27:S9-15.
14. Enriquez LJ, Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms. Br J Anaesth 2009;103(suppl 1):i14-22.
15. Olde Engberink RH, Kuiper G, Wetzels RJH, et al. Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery. J Cardiothorac Vasc Anesth 2014;28:210-6.
16. Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilutioninduced coagulation changes after cardiac surgery. Transfusion 2012;52:14-22.
17. Theusinger OM, Schröder CM, Eismon J, et al. The influence of laboratory coagulation tests and clotting factor levels on rotation thromboelastometry (ROTEM®) during major surgery with hemorrhage. Anesth Analg 2013;117:314-21.
18. Görlinger K, Shore-Lesserson L, Dirkmann D, et al. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 2013;27:S20-34.
19. Tanaka KA, Bolliger D, Vadlamudi R, et al. Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J Cardiothorac Vasc Anesth 2012;26:1083-93.
20. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10.
21. Ranucci M, Baryshnikova E. Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). Br J Anaesth 2016;116:618-23.
22. Weiss G, Lison S, SpannaglM, et al. Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010;105:429-36.
23. Blasi A, Muñoz G, de Soto I, et al. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement. Thromb Res 2015;136:669-72.
24. Karger R, Schmidt J, Weber C, et al. In-line filtration of autologous whole blood. Transfusion 2006;46:811-7.
25. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg 2011;91:944-82.
26. Frietsch T, Karger R, Schöler M, et al. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay. Transfusion 2008;48:2133-42.
27. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion 1998;38:296-300.
28. Glenister KM, Sparrow RL. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter. Transfusion 2010;50:185-9.
29. Domen RE, Hoeltge GA. Allergic transfusion reactions-An evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003;127:316-20.
30. Availlable at: http://www.jsat.jp/jsat-web/down-load/pdf/cyoketsushiki jikoketsu-shishin2014.pdf (in Japanese). Accessed May 6, 2018